• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛卵泡抑制素的九种不同生物活性和免疫活性分子变体的分离

Isolation of nine different biologically and immunologically active molecular variants of bovine follicular inhibin.

作者信息

Good T E, Weber P S, Ireland J L, Pulaski J, Padmanabhan V, Schneyer A L, Lambert-Messerlian G, Ghosh B R, Miller W L, Groome N

机构信息

Molecular Reproductive Endocrinology Laboratory, Department of Animal Science, East Lansing, Michigan 48824, USA.

出版信息

Biol Reprod. 1995 Dec;53(6):1478-88. doi: 10.1095/biolreprod53.6.1478.

DOI:10.1095/biolreprod53.6.1478
PMID:8562706
Abstract

A combination of immunoaffinity chromatography, SDS-PAGE, and electroelution was used to simultaneously isolate 0.36-4.65 mg of nine different molecular forms of inhibin (pro alpha C-29 kDa; fully processed 34 kDa; and large inhibin forms 49, 53, 58, 77, 88, 110, and > 160 kDa) from 0.675 L of bovine follicular fluid (bFF). Each inhibin form, except pro alpha C, cross-reacted with inhibin alpha C 1-26-and beta A 82-114-subunit-directed antibodies during immunoblot analysis. Pro alpha C cross-reacted only with alpha-subunit antibodies. The inhibin forms consisted of 22-, 29-, 49-, or 58-kDa alpha subunits and 17- or 58-kDa beta subunits. During cultures of ovine pituitary cells, a 5-ng/ml dose of each inhibin form (except pro alpha C) suppressed basal accumulation of FSH 30% to 50% but increased GnRH-induced LH release 40% to 248%. The various inhibin forms cross-reacted in parallel fashion with standard curves generated during homologous and heterologous RIAs but with markedly different relative immunopotencies. In the RIAs, pro alpha cross-reacted 3- to 18-fold more than the fully processed inhibin form. The fully processed and the seven different large forms of inhibin cross-reacted with different relative immunopotencies in a two-site dimer-specific ELISA. We concluded that 1) a combination of immunoaffinity extraction, SDS-PAGE, and electroelution simultaneously isolated relatively large amounts of highly enriched preparations of nine different molecular forms of immunologically and biologically active inhibin from bFF; 2) eight different dimeric forms of bovine inhibin may regulate both basal FSH and GnRH-induced LH secretion by the pituitary gland, and 3) eight or nine different molecular forms of inhibin cross-react with different relative immunopotencies in the two-site dimer-specific assay or RIAs.

摘要

采用免疫亲和色谱、SDS - 聚丙烯酰胺凝胶电泳(SDS - PAGE)和电洗脱相结合的方法,从0.675升牛卵泡液(bFF)中同时分离出0.36 - 4.65毫克9种不同分子形式的抑制素(前αC - 29 kDa;完全加工的34 kDa;以及大抑制素形式49、53、58、77、88、110和>160 kDa)。除前αC外,每种抑制素形式在免疫印迹分析中均与抑制素αC 1 - 26和βA 82 - 114亚基导向抗体发生交叉反应。前αC仅与α亚基抗体发生交叉反应。抑制素形式由22 kDa、29 kDa、49 kDa或58 kDa的α亚基和17 kDa或58 kDa的β亚基组成。在绵羊垂体细胞培养过程中,每种抑制素形式(除前αC外)5纳克/毫升的剂量可使基础促卵泡激素(FSH)积累量抑制30%至50%,但使促性腺激素释放激素(GnRH)诱导的促黄体生成素(LH)释放增加40%至248%。各种抑制素形式在同源和异源放射免疫分析(RIA)过程中与标准曲线以平行方式发生交叉反应,但相对免疫活性明显不同。在RIA中,前α的交叉反应比完全加工的抑制素形式高3至18倍。在双位点二聚体特异性酶联免疫吸附测定(ELISA)中,完全加工的抑制素和7种不同的大抑制素形式以不同的相对免疫活性发生交叉反应。我们得出以下结论:1)免疫亲和提取、SDS - PAGE和电洗脱相结合的方法可从bFF中同时分离出相对大量的、高度富集的9种不同分子形式的具有免疫活性和生物活性的抑制素制剂;2)8种不同的牛抑制素二聚体形式可能调节垂体的基础FSH和GnRH诱导的LH分泌;3)8或9种不同分子形式的抑制素在双位点二聚体特异性测定或RIA中以不同的相对免疫活性发生交叉反应。

相似文献

1
Isolation of nine different biologically and immunologically active molecular variants of bovine follicular inhibin.牛卵泡抑制素的九种不同生物活性和免疫活性分子变体的分离
Biol Reprod. 1995 Dec;53(6):1478-88. doi: 10.1095/biolreprod53.6.1478.
2
Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid.牛卵泡液中高分子量抑制素形式的纯化与特性分析
Endocrinology. 1992 Feb;130(2):789-96. doi: 10.1210/endo.130.2.1733725.
3
Alterations in intrafollicular levels of different molecular mass forms of inhibin during development of follicular- and luteal-phase dominant follicles in heifers.小母牛卵泡期和黄体期优势卵泡发育过程中卵泡内不同分子量形式抑制素水平的变化。
Biol Reprod. 1996 Feb;54(2):453-62. doi: 10.1095/biolreprod54.2.453.
4
Alterations in amounts of different forms of inhibin during follicular atresia.
Biol Reprod. 1994 Jun;50(6):1265-76. doi: 10.1095/biolreprod50.6.1265.
5
Molecular weight forms of inhibin a and inhibin B in the bovine testis change with age.牛睾丸中抑制素α和抑制素β的分子量形式随年龄变化。
Biol Reprod. 2003 May;68(5):1918-25. doi: 10.1095/biolreprod.102.012856. Epub 2002 Dec 27.
6
The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma.人卵泡液和血浆中抑制素A和B形式的生物学及免疫学特征
J Clin Endocrinol Metab. 1997 Mar;82(3):889-96. doi: 10.1210/jcem.82.3.3801.
7
Isolation of a 31 kDa form of inhibin from bovine follicular fluid.从牛卵泡液中分离出一种31 kDa形式的抑制素。
Mol Cell Endocrinol. 1986 Mar;44(3):271-7. doi: 10.1016/0303-7207(86)90133-4.
8
Evidence that the bovine ovary secretes large amounts of monomeric inhibin alpha subunit and its isolation from bovine follicular fluid.牛卵巢分泌大量单体抑制素α亚基的证据及其从牛卵泡液中的分离。
J Mol Endocrinol. 1989 May;2(3):189-200. doi: 10.1677/jme.0.0020189.
9
The radioimmunoassay of bovine and human follicular fluid and serum inhibin.
Mol Cell Endocrinol. 1986 Jul;46(2):175-85. doi: 10.1016/0303-7207(86)90096-1.
10
Isolation of bovine follicular fluid inhibin of about 32 kDa.分离出约32 kDa的牛卵泡液抑制素。
Mol Cell Endocrinol. 1986 Jan;44(1):55-60. doi: 10.1016/0303-7207(86)90105-x.

引用本文的文献

1
Comparing the potential for maternal-fetal signalling in oviparous and viviparous lizards.比较卵生和胎生蜥蜴中母体-胎儿信号传递的潜力。
Philos Trans R Soc Lond B Biol Sci. 2022 Dec 5;377(1865):20210262. doi: 10.1098/rstb.2021.0262. Epub 2022 Oct 17.
2
'Free' inhibin α subunit is expressed by bovine ovarian theca cells and its knockdown suppresses androgen production.牛卵巢膜细胞表达“游离”抑制素 α 亚单位,其敲低可抑制雄激素的产生。
Sci Rep. 2019 Dec 24;9(1):19793. doi: 10.1038/s41598-019-55829-w.
3
Inhibin at 90: from discovery to clinical application, a historical review.
抑制素90年:从发现到临床应用,历史回顾
Endocr Rev. 2014 Oct;35(5):747-94. doi: 10.1210/er.2014-1003. Epub 2014 Jul 22.